Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1996-08-27
1998-05-26
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 185, 564219, 564340, 564341, A61K 5104, C07C32325, C07C32341
Patent
active
057560684
ABSTRACT:
Compounds useful in radioimaging and radiochemotherapy as it particularly relates to the treatment and location of malignant melanomas and other pigmenting disorders, as well as novel acyl derivatives of phenolic thioester amines and their use in compositions for blocking melanin synthesis in human or animal melanocyte cells.
REFERENCES:
patent: 4134996 (1979-01-01), Dunbar et al.
patent: 4183927 (1980-01-01), Begin et al.
patent: 5283342 (1994-02-01), Gustavson et al.
patent: 5395611 (1995-03-01), Jimbow
Synthesis of Cysteinylphenol, Cysteaminylphenol, and Related Compounds, and in Vivo Evaluation of Antimelanoma Effect by S. Miura, T. Ueda, K. Jimbow, S. Ito, K. Fujita--Arch. Dermatol. Res. 279:219-225, 1987.
Depigmentation of Back Guinea Pig Skin by Topical Application of Cysteaminylphenol, Cysteinylphenol, and Related Compounds by Y. Ito, K. Jimbow, S. Ito--J. Invest. Dermatol. 88:77-82, 1987.
Selective Cytotoxicity of 4-S-Cysteaminylphenol on Follicular Melanocytes of the Black Mouse: Rational Basis for Its Application to Melanoma Chemotherapy by Y. Ito, K. Jimbow--Cancer Res. 47:3278-3284, 1987.
Selective Cytotoxicity of N-acetyl-4-S-cysteaminylphenol on Follicular Melanocytes of Black Mince by M. Wong, K. Jimbow--Brit. J. Dermatol. 124:56-61, 1991.
Selective Cytotoxicity of a Phenolic Melanin Precursor, 4-S-Cysteaminylphenol, on in Vitro Melanoma Cells by K. Yamada, K. Jimbow, R. Engelhardt, S. Ito--Biochem Pharmacology 38:2217-2221, 1989. for the Development of an Antimelanoma and Melanomaradioimaging Agent by T. Iwashina, K. Jimbow, L. I. Wiebe--Appl Radiat Isot 45:703-705, 1994.
Reactivity of Orthoquinones Involved in Tyrosinase-Dependent Cytotoxicity: Differences Between Alkylthio- and Alkoxy-Substituents by C.J. Cooksey, K. Jimbow, E.J. Land, P.A. Riley--Melanoma Res 2:283-293, 1992.
Phenolic Melanin Precursors Provide a Rational Approach to the Design of Antitumor Agents for Melanoma by K. Jimbow, T. Miura, S. Ito, K. Ishikawa--Pigment Cell Res 2:34-39, 1989.
Jimbow et al., "Exploitation of Pigment Biosynthesis Pathway as a Selective Chemotherapeutic Approach for Malignant Melanoma, " The Journal of Investigative Dermatology, vol. 100, No. 2, Feb. 1993, pp. 231S-238S.
4-S-Cysteaminylphenol and its Analogues as Substrates for Tyrosinase and Monoamine Oxidase by J.M. Pankovich, K. Jimbow, S. Ito--Pigment Cell Res 3:146-149, 1990.
Experimental Antimelanoma Agents: The Synthesis of 4-S-Cysteaminyl and Excerpta Medica 20:158-159, 1989.
Mechanism of Growth Inhibition of Melanoma Cells by 4-S-Cystteaminylphenol and its Analogues by S. Inoue, S. Ito, K. Wakamatsu, K. Jimbow, K. Fujita--Biochem Pharmacol 39:1077-1083, 1990.
Melanocytotoxicity and Antimelanoma Effects of Phenolic Amine Compounds in Mice in Vivo by F. Alena, K. Jimbow, S. Ito--Cancer Research 50.3743-3747 Jun. 15, 1990.
N-Acetyl-4-S-cysteaminylphenol as a New Type of Depigmenting Agent for the Melanoderma of Patients with Melasma by K. Jimbow--Arch Dermatol 172:1528-1534, 1991.
Action of Cysteaminylphenols on Human Melanoma Cells in Vivo and in Vitro: 4-S-Cysteaminylphenol Binds Protein Disulphide Isomerase by P.G. Parsons, D. Favier, M. McEwan, H. Takahashi, K. Jimbow, S. Ito--Melanoma Res 1:97-104, 1991.
Selective in Vivo and in Vitro Incorporation and Accumulation of Phenolic Thioeter Amine into Malignant Melanoma and Indentification of a (58 kD) Binding Glycoprotein by K. Yamada, K. Jimbow--Melanoma Res 2:225-233, 1992.
Glutathione Plays a Key Role in the Depigmenting and Melanocytotoxic Action of N-Acetyl-4-S-Cysteaminylphenol in Black and Yellow Hair Follicles by F. Alena, W. Dixon, P. Thomas, K. Jimbow--J. Invest Dermatol 104:792-797, 1995.
Selective in Vivo Accumulation of N-Acetyl-4-S-Cysteaminylphenol in B16F10 Murine Melanoma and Enhancement of its in Vitro and in Vivo Antimelanoma Effect by Combination of Buthionine Sulfoximine by F. Alena, T. Iwashina, A. Gili, K. Jimbow--Cancer Res 54:2661-2666, 1994.
The in Vivo Melanocytotoxicity and Depigmenting Potency of N-2,4-Acetoxyphenyl Thioethyl Acetamide in the Skin and Hair by M. Jimbow, H. Murusyk, K. Jimbow--British J. Dermatol (in press), 1995.
The in Vivo Antimelanoma Effect of 4-S-Cysteaminylphenol and its N-Acetyl Derivative by T. Miura, K. Jimbow, S. Ito--Int. J. Cancer 46:931-934, 1990.
Malignant Melanoma: A Life Threatening Skin Cancer Affecting Young People--Its Diagnosis and Management by G.J. Lauzon, K. Jimbow--Am Royal Col Phys Surg 23:105-110, 1990.
Electron Donor and Acceptor Properties of Melanin Pigments in the Skin by K. Reszka, K. Jimbow--In: Oxidative Stress in Dermatology, ed by Fuchs J and Packer J. Marcel Dekker Inc., New York, pp. 287-320, 1993.
Hartley Michael G.
Hollinden Gary E.
The Governors of the University of Alberta
LandOfFree
Methods of radioimaging and radiochemotherapy using phenolic thi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of radioimaging and radiochemotherapy using phenolic thi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of radioimaging and radiochemotherapy using phenolic thi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1957175